SyqeAir is making waves! We’re proud to share that Israel21c has recognized the SyqeAir Inhaler as one of the 12 most amazing Israeli medical advances.
This honor highlights our innovative work in medical cannabis treatment, delivering a metered-dose, safe, and effective solution for patients living with chronic neuropathic pain and PTSD to allow them to maintain an optimal daily routine and improve their quality of life.
The pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial
Syqe®’s third study (2020) evaluated the SyqeAir Inhaler as a solution for safe, consistent, and low-dose medical cannabis treatment in patients with chronic neuropathic pain. Listen to the podcast.